Gert van Valkenhoef

5.3k total citations · 2 hit papers
33 papers, 2.6k citations indexed

About

Gert van Valkenhoef is a scholar working on Statistics, Probability and Uncertainty, Economics and Econometrics and Statistics and Probability. According to data from OpenAlex, Gert van Valkenhoef has authored 33 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Statistics, Probability and Uncertainty, 9 papers in Economics and Econometrics and 9 papers in Statistics and Probability. Recurrent topics in Gert van Valkenhoef's work include Meta-analysis and systematic reviews (11 papers), Statistical Methods in Clinical Trials (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Gert van Valkenhoef is often cited by papers focused on Meta-analysis and systematic reviews (11 papers), Statistical Methods in Clinical Trials (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Gert van Valkenhoef collaborates with scholars based in Netherlands, United Kingdom and United States. Gert van Valkenhoef's co-authors include A. E. Ades, Hans L. Hillege, Nicky J. Welton, Bert de Brock, Tommi Tervonen, Sofia Dias, Guobing Lu, Douwe Postmus, Orestis Efthimiou and Thomas P. A. Debray and has published in prestigious journals such as Journal of the American College of Cardiology, JNCI Journal of the National Cancer Institute and Scientific Reports.

In The Last Decade

Gert van Valkenhoef

32 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Automating network meta‐analysis

2012 577 citations Gert van Valkenhoef, Bert de Brock et al. Research Synthesis Methods profile →
Automated generation of node‐splitting models for assessment of inconsistency in network meta‐analysis

2015 446 citations Gert van Valkenhoef, Sofia Dias et al. Research Synthesis Methods profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gert van Valkenhoef Netherlands	20	571	377	366	325	319	33	2.6k
Stéphane Héritier Australia	33	446 0.8×	345 0.9×	376 1.0×	187 0.6×	512 1.6×	133	3.6k
Christian Ohmann Germany	39	1.4k 2.4×	448 1.2×	328 0.9×	201 0.6×	122 0.4×	178	4.2k
Gernot Wassmer Germany	27	479 0.8×	405 1.1×	495 1.4×	197 0.6×	1.1k 3.4×	80	3.8k
Kit C. B. Roes Netherlands	28	208 0.4×	224 0.6×	335 0.9×	377 1.2×	645 2.0×	143	2.9k
Hubert J. A. Schouten Netherlands	28	345 0.6×	218 0.6×	327 0.9×	212 0.7×	269 0.8×	62	2.9k
Danielle Burke United Kingdom	18	414 0.7×	572 1.5×	288 0.8×	232 0.7×	215 0.7×	35	2.5k
Danica Marinac‐Dabic United States	21	793 1.4×	398 1.1×	553 1.5×	90 0.3×	218 0.7×	79	2.7k
Rae Woong Park South Korea	28	433 0.8×	331 0.9×	377 1.0×	49 0.2×	142 0.4×	191	3.7k
Susan F. Assmann United States	35	703 1.2×	493 1.3×	1.2k 3.2×	164 0.5×	269 0.8×	69	5.9k
Timothy Collier United Kingdom	34	613 1.1×	344 0.9×	1.1k 3.1×	176 0.5×	293 0.9×	80	3.8k

Countries citing papers authored by Gert van Valkenhoef

Since Specialization

Citations

This map shows the geographic impact of Gert van Valkenhoef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert van Valkenhoef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert van Valkenhoef more than expected).

Fields of papers citing papers by Gert van Valkenhoef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gert van Valkenhoef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert van Valkenhoef. The network helps show where Gert van Valkenhoef may publish in the future.

Co-authorship network of co-authors of Gert van Valkenhoef

This figure shows the co-authorship network connecting the top 25 collaborators of Gert van Valkenhoef. A scholar is included among the top collaborators of Gert van Valkenhoef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gert van Valkenhoef. Gert van Valkenhoef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Veer, Emil ter, Lok Lam Ngai, Gert van Valkenhoef, et al.. (2017). Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis. Scientific Reports. 7(1). 7142–7142. 20 indexed citations

Efthimiou, Orestis, Thomas P. A. Debray, Gert van Valkenhoef, et al.. (2016). GetReal in network meta‐analysis: a review of the methodology. Research Synthesis Methods. 7(3). 236–263. 268 indexed citations

Veer, Emil ter, Nadia Haj Mohammad, Gert van Valkenhoef, et al.. (2016). Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature. Cancer and Metastasis Reviews. 35(3). 439–456. 32 indexed citations

Veer, Emil ter, Nadia Haj Mohammad, Gert van Valkenhoef, et al.. (2016). The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis. JNCI Journal of the National Cancer Institute. 108(10). djw166–djw166. 86 indexed citations

Valkenhoef, Gert van, Russell F. Loane, & Deborah A. Zarin. (2016). Previously unidentified duplicate registrations of clinical trials: an exploratory analysis of registry data worldwide. Systematic Reviews. 5(1). 116–116. 19 indexed citations

Valkenhoef, Gert van, Sofia Dias, A. E. Ades, & Nicky J. Welton. (2015). Automated generation of node‐splitting models for assessment of inconsistency in network meta‐analysis. Research Synthesis Methods. 7(1). 80–93. 446 indexed citations breakdown →

Velde, K. Joeri van der, Joël Kuiper, Bryony A. Thompson, et al.. (2015). Evaluation of CADD Scores in Curated Mismatch Repair Gene Variants Yields a Model for Clinical Validation and Prioritization. Human Mutation. 36(7). 712–719. 29 indexed citations

Tervonen, Tommi, Huseyin Naci, Gert van Valkenhoef, et al.. (2015). Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment. Medical Decision Making. 35(7). 859–871. 41 indexed citations

Valkenhoef, Gert van, Joël Kuiper, & Joël Kuiper. (2014). Crowdsourcing a Comprehensive Clinical Trial Repository. University of Groningen research database (University of Groningen / Centre for Information Technology). 2 indexed citations

10.

Naci, Huseyin, Gert van Valkenhoef, Julian P. T. Higgins, Rachael Fleurence, & A. E. Ades. (2014). Evidence-Based Prescribing. Circulation Cardiovascular Quality and Outcomes. 7(5). 787–792. 23 indexed citations

11.

Sun, Ying, Gert van Valkenhoef, & Thomas Morel. (2014). A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome. Current Medical Research and Opinion. 30(11). 2267–2278. 12 indexed citations

12.

Postmus, Douwe, Tommi Tervonen, Gert van Valkenhoef, Hans L. Hillege, & Erik Buskens. (2013). A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions. The European Journal of Health Economics. 15(7). 709–716. 14 indexed citations

13.

Valkenhoef, Gert van, Tommi Tervonen, Bert de Brock, & Hans L. Hillege. (2012). Clinical trials information in drug development and regulation: existing systems and standards. 19 indexed citations

14.

Zhao, Jing, et al.. (2012). ADDIS: an automated way to do network meta-analysis. University of Groningen research database (University of Groningen / Centre for Information Technology). 10 indexed citations

15.

Valkenhoef, Gert van, Tommi Tervonen, Bert de Brock, & Hans L. Hillege. (2012). Deficiencies in the transfer and availability of clinical trials evidence: a review of existing systems and standards. BMC Medical Informatics and Decision Making. 12(1). 95–95. 17 indexed citations

16.

Vlaar, Pieter J., Karim D. Mahmoud, David R. Holmes, et al.. (2011). Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. 58(7). 692–703. 201 indexed citations

17.

Tervonen, Tommi, Gert van Valkenhoef, Erik Buskens, Hans L. Hillege, & Douwe Postmus. (2011). A stochastic multicriteria model for evidence‐based decision making in drug benefit‐risk analysis. Statistics in Medicine. 30(12). 1419–1428. 78 indexed citations

18.

Valkenhoef, Gert van, Tommi Tervonen, Jing Zhao, et al.. (2011). Multicriteria benefit–risk assessment using network meta-analysis. Journal of Clinical Epidemiology. 65(4). 394–403. 55 indexed citations

19.

Valkenhoef, Gert van, Tommi Tervonen, Bert de Brock, & Hans L. Hillege. (2011). Algorithmic parameterization of mixed treatment comparisons. Statistics and Computing. 22(5). 1099–1111. 26 indexed citations

20.

Valkenhoef, Gert van, Tommi Tervonen, Bert de Brock, & Douwe Postmus. (2011). Quantitative release planning in extreme programming. Information and Software Technology. 53(11). 1227–1235. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact